Nelson C - Search Results

1

Biomarker and translational prostate cancer research.

Doll A, Clark J, Nelson C. Doll A, et al. Among authors: nelson c. Biomed Res Int. 2015;2015:309851. doi: 10.1155/2015/309851. Epub 2015 Jan 15. Biomed Res Int. 2015. PMID: 25664317 Free PMC article. No abstract available.

2

Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model.

Sieh S, Lubik AA, Clements JA, Nelson CC, Hutmacher DW. Sieh S, et al. Among authors: nelson cc. Organogenesis. 2010 Jul-Sep;6(3):181-8. doi: 10.4161/org.6.3.12041. Organogenesis. 2010. PMID: 21197221 Free PMC article.

3

Insulin increases de novo steroidogenesis in prostate cancer cells.

Lubik AA, Gunter JH, Hendy SC, Locke JA, Adomat HH, Thompson V, Herington A, Gleave ME, Pollak M, Nelson CC. Lubik AA, et al. Among authors: nelson cc. Cancer Res. 2011 Sep 1;71(17):5754-64. doi: 10.1158/0008-5472.CAN-10-2470. Epub 2011 Jul 11. Cancer Res. 2011. PMID: 21747118 Free article.

4

From bench to bedside: immunotherapy for prostate cancer.

Tse BW, Jovanovic L, Nelson CC, de Souza P, Power CA, Russell PJ. Tse BW, et al. Biomed Res Int. 2014;2014:981434. doi: 10.1155/2014/981434. Epub 2014 Sep 4. Biomed Res Int. 2014. PMID: 25276838 Free PMC article. Review.

5

The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer.

Soekmadji C, Nelson CC. Soekmadji C, et al. Among authors: nelson cc. Biomed Res Int. 2015;2015:454837. doi: 10.1155/2015/454837. Epub 2015 Oct 26. Biomed Res Int. 2015. PMID: 26587537 Free PMC article. Review.

6

Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.

Soekmadji C, Corcoran NM, Oleinikova I, Jovanovic L; Australian Prostate Cancer Collaboration BioResource; Ramm GA, Nelson CC, Jenster G, Russell PJ. Soekmadji C, et al. Among authors: nelson cc. Prostate. 2017 Oct;77(14):1416-1423. doi: 10.1002/pros.23403. Epub 2017 Aug 29. Prostate. 2017. PMID: 28856701 Review.

7

Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.

Miyake H, Nelson C, Rennie PS, Gleave ME. Miyake H, et al. Among authors: nelson c. Cancer Res. 2000 May 1;60(9):2547-54. Cancer Res. 2000. PMID: 10811138

8

Application of gene microarrays in the study of prostate cancer.

Nelson CC, Hoffart D, Gleave ME, Rennie PS. Nelson CC, et al. Methods Mol Med. 2003;81:299-320. doi: 10.1385/1-59259-372-0:299. Methods Mol Med. 2003. PMID: 12725128 No abstract available.

9

Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.

Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C, Gleave M. Rocchi P, et al. Among authors: nelson c. Cancer Res. 2005 Dec 1;65(23):11083-93. doi: 10.1158/0008-5472.CAN-05-1840. Cancer Res. 2005. PMID: 16322258

10

Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME, Nelson CC. Locke JA, et al. Among authors: nelson cc. Cancer Res. 2008 Aug 1;68(15):6407-15. doi: 10.1158/0008-5472.CAN-07-5997. Cancer Res. 2008. PMID: 18676866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,970 results

Search Page